A B S T R A C T This study reports the development of a specific and sensitive radioimmunoassay and a simple and accurate radial immunodiffusion (RID) assay for the human serum-binding protein for vitamin D and its metabolites (DBP). These iminunoassays employed a monospecific antisertum that was prepared in rabbits against human DBP. The radioimmunoassay effectively measured DBP in amounts of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 
of a specific and sensitive radioimmunoassay and a simple and accurate radial immunodiffusion (RID) assay for the human serum-binding protein for vitamin D and its metabolites (DBP) . These iminunoassays employed a monospecific antisertum that was prepared in rabbits against human DBP. The radioimmunoassay effectively measured DBP in amounts of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] '432-442 human DBP. With these immunoassays, the levels of DBP in the serum of normal persons and in patients with various clinical disorders were determined. The relationships between the serum levels of DBP and 25-OH-D were also explored. Immunological identity between DBP and the group-specific component (Gc) proteins in plasma was demonstrated, in support of the conclusion of a recent report by Daiger et al. (2) . Some of these findings have been reported in abstract form (3) .
METHODS
Human DBP. DBP wvas isolated from plasma as described previously (1) . The preparation of purified DBP used in the studies reported here was the same preparation we described and partially characterized in our previous publication (1) .
Preparation of antiserum. An antiserum against human DBP was raised in a white rabbit weighing 2.4 kg. 1.5 mg DBP was dissolved in 0.75 ml of 0.1 M potassium phosphate buffer, pH 7.4, and the solution was emulsified with an equal volume of complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). Immunization was carried out as described previously for the preparation of a rabbit antiserum against rat retinol-binding protein (4) . 2 wk after the booster injection, and at weekly intervals thereafter, blood was collected from ear veins or arteries. After clotting, the blood samples were centrifuged at 1,500 rpm for 20 min at 4°C, and the sera were collected and stored at -60°C.
Double immunodiffusion in gel studies of this antiserum showed that it was not monospecific and displayed two major precipitin lines when reacted against human whole sertum. Only one precipitin line was seen on immunodiffusion of this antiserum against the purified DBP preparation, and this major precipitin line showved a reaction-of-identity with one of the two lines obtained with whole serum. After drying and staining the immunodiffusion gel, however, a faint minor precipitin line was also seen after double diffuision of this antiserum against the purified DBP preparation.
The immunogen responsible for the formation of the second (contaminating) precipitin line (not containing DBP) was identified by immunodiffusion studies in which this anti-DBP antiserum and each of several other available antisera were reacted together against human whole serum. The sera tested included rabbit antisera against the following human plasma proteins: al-antitrypsin, al-acid glycoprotein, inter-a-trypsin inhibitor, a2-HS glycoprotein (all purchased from Behring Diagnostics, American Hoechst Corp., Somerville, N. J.), and corticosteroid-binding globulin (a gift from Dr. William Rosner, Roosevelt Hospital and the Columbia University College of Physicians and Surgeons, New York). The second precipitin line obtained on immunodiffusion of the anti-DBP antiserum against whole serum showed a reaction-of-identity with the precipitin line obtained with the anti-al-antitrypsin antiserum.
A monospecific antiserum against human DBP vas raised in other rabbits by injecting them with precipitin lines containing the DBP and rabbit immunoglobulin. The precipitin lines used for this purpose were prepared by immunoelectrophoresis of a solution of the isolated DBP preparation, which resulted in a wide separation of the major precipitin line against DBP from the minor contaminating precipitin line (see Fig. 1 emulsion intramuscularly into the thigh and with 0.6 ml subcutaneously in both scapula regions. Immediately thereafter, 0.5 inl of pertussis vaccine was injected subcutaneously in the back of the neck. Each rabbit received booster injections of the emulsified precipitin lines 2 wk later (0.1 ml into each of four toe pads, 0.5 ml into the right thigh muscle, and 1 ml subcutaneously), and onie of the two rabbits received additional booster injections 2 wks after that. Both rabbits were bled weekly after the last booster injection, and the serum was collected and stored at -600C. 14 and 17 lots of sera were collected from the two rabbits, respectively, during a 4-5-mo interval. One of these lots of monospecific anti-DBP antiserum was used in all of the subse(quent studies reported in this paper. Before the development of the radioimmunoassay, a study was conducted to estimate the antibody titer of the anti-DBP antiserum and to determine the appropriate dilution of antiserum for use in the immunoassay. It was determined that at a final dilution of 1:25,000 of antiserum, from 40 to 50% of the '25I-DBP (in the amount used in the radioimmunoassay, see below) was bound to antibody in the absence of added unlabeled DBP.
The radioimmunoassay procedure emnployed PBS containing 0.1% NaN3 and 2.5% normal rabbit serumn as buffer solution for all dilutions. Reagents were added to 1.0 x 7.5-cmll tubes in the following order: (a) 150 ,ul diluting buffer, (b) 50 ,ul 0.1 M EDTA (Na salt), pH 7.4; (c) a 100-,l sample to be assayed (suitably diluted serum or standard DBP solution); (d) 100l A '251-DBP, about 10,000 cpm; and (e) 100 gl anti-DBP antiserumil, diluted 1:5,000 to give a final dilution of 1:25,000. After incubation in the dark at 4°C for 3 days, antibody-bounld and free 1251-DBP were separated by precipitating the imniunoglobulin with polyethylenie glycol, 6,000-7,500 mol wt (Matheson, Coleman and Bell, Norwood, Ohio), as suggested by Desbuquois and Aurbach (9) . To the 0.5 ml of assay mixture in each tube, 1.5 ml of 16% (wt/vol) polyethylene glycol in PBS containing 0.8 mg/ml of normal rabbit y-globulini ( Radial immunodiffusion assay of DBP. A single radial immunodiffusion (RID) assay for DBP in human serum was developed according to the method of Mancini et al. (11) with some modifications. Immunodiffusion plates were prepared using 3.5 ml of 1% agarose containing 2% rabbit anti-DBP antiserum in PBS with 0.1% NaN3 per plate. Gels were poured on 2.4 x 7.2-cm diffusion plates (ImmunoPlate, Hyland Div., Travenol Laboratories, Inc., Costa Mesa, Calif.). 12 wells, each with a 2-mm diameter were punched out per plate. 5-,ul standards or samples to be assayed were applied into the wells and the plates were kept in a humid chamber. About 48 h later, when no further extension of precipitin rings was observed, the diameter of each precipitin ring was measured using a magnifying comparator (Meloy Laboratories, Inc., Springfield, Va.). A standard curve was prepared by plotting the square of the diameter of the precipitin ring against the known amount of DBP added to the well for each sample of a series of dilutions of a solution of purified DBP. The resulting plot was linear and could be used as an effective immunoassay with amounts of DBP added per well in the range of 0.2-0.8 ,ug.
The standard used for most RID assay runs was a sample of normal human whole serum which was standardized against purified DBP dissolved in PBS. The standard whole serum (0.45 mg of DBP per ml) was diluted 3:7 (vol/vol) with PBS, divided into small portions, and stored at -20°C. For each assay run, several dilutions of the standard whole serum were prepared from one freshly thawed portion, and these samples were used to provide the standard curve for that assay run.
Serum samples for RID assay were diluted 1:4 (vol/vol) with PBS before assay. Samples were routinely assayed in duplicate, and the mean of the pair of values was taken as the final value.
The recovery of DBP in the RID assay was determined by assaying a series of mixtures of a sample of normal serum and of a solution of purified DBP. For this study, the normal serum was diluted 1:4 with PBS, and the purified DBP was dissolved in PBS at a concentration of 0.109 mg/ml. Portions of these two solutions were mixed in different ratios to make five samples for study. The recovery of pure DBP in the assay was estimated by subtracting the DBP added with the serum in each sample from the total amount of immunoreactive DBP observed.
Assay for serum 25-OH-D. Seruim 25-OH-D levels were determined by a competitive protein-binding assay, using normal diluted (1:4,000) human serum as the source of binding protein. The assay was generally similar to competitive protein-binding assays reported by others (12) (13) (14) (15) (16) , except that the reported assays have used other sources of binding proteins, including kidney cytosol from rachitic rats (12) , serum from normal (13) and rachitic (14, 15) rats, and plasma from an osteomalacic man (16) . Serum was extracted by shaking the 0.5-ml sample with 2 ml of ethanol and 3 ml of hexane; phase separation was achieved by adding 2 ml of water and centrifuging. The hexane phase was collected and the residue was re-extracted with 3 ml hexane. After evaporation of the combined hexane phases to dryness, the lipid extract was chromatographed on a 1 x 20-cm column of Sephadex LH-20 (Pharmacia Fine Chemicals) (17) using chloroform:hexane, 1:1 (vol/vol) as eluate. The first 20 ml of eluate was discarded and the second 20 ml, containing 25-OH-D, was collected and evaporated to dryness under N2. The residue was dissolved in exactly 1 ml ethanol for further assay. Of this, 0.5 ml was assayed for 3H to assess the recovery of 25 ,LI ethanol had been added to the 0.5 ml serum sample before extraction). The recovery was approximately 95% (range, 87-100%).
The competitive binding assay was performed as follows. The samples to be assayed, dissolved in ethanol, were each added to one of a series of test tubes, as were standard amounts of pure unlabeled 25-OH-D3 varying from 0.1 to 10 ng per tube. All samples were asssayed in duplicate. To assess nonspecific binding, tubes containing 400 ng of unlabeled 25-OH-D3 were also prepared. After evaporating the ethanol, 0.002 nmol (approximately 30,000 dpm) of [3H]25-OH-D3 in 100 ,ul ethanol was added to each tube, followed by 1 ml of human whole serum diluted 1:4,000 with PBS. After incubation on ice for 60 min, 0.2 ml dextran-coated charcoal and 0.2 ml PBS were added, followed by 20 min further incubation. The mixtures were centrifuged for 10 min at 1,500 rpm at 4°C. Exactly 1 ml of each supernate was transferred to a scintillation vial, mixed with 10 (18) . Samples were obtained as well from five patients with chronic liver disease and from nine patients with chronic renal disease. The former patients were all diagnosed as having cirrhosis of the liver. Four of these patients were studied while hospitalized for their liver disease. All five patients had clinical and laboratory evidence of hepatocellular dysfunction; the mean serum albumin level was 2.9 g/dl. The patients with renal disease were all being treated with chronic hemodialysis for renal failure. The samples were collected just before the start of a dialysis treatment. The mean serum calcium level in the nine patients was 8.7 mg/dl (range, 7.2-9.7).
Blood was obtained from six patients with symptomatic Paget's disease. Three of the patients were being treated with mithramycin, and had mild hypocalcemia (calcium levels of 7.9-8.5 mg/dl) as a consequence oftherapy. The other three patients were normocalcemic.
Samples were obtained from three patients with hypoparathyroidism who were taking large doses of oral supplements of vitamin D2 (50,000-100,000 IU per day). Two of the patients had clinical evidence ofvitamin D toxicity and hypercalcemia (calcium levels of 21 DBP-depleted serum was prepared by inctubatinig 3 g of anti-DBP-substituted Sepharose (wet weight) with 1 ml of human whole serum for 3 h at 4°C. After centrifuging the mixture for 10 min at 5,000 rpm at 4°C, the restulting supernate was concentrated by ultrafiltration (Minicon concentrators A-25, Amicon Corp., Lexington, Mass.); the sample was then adjusted to the original total protein concentration in the starting serum. A control sample was prepared by identical treatment of a second 1 ml of whole sertum witlh the control preparation of immunoglobulin-stubstituted Sepharose. These serum samples were used for immtunodiffusion studies with anti-human Gc protein antiserum.
An experiment was conducted to study the effect of DBP depletion with the anti-DBP-stubstituted Sepharose on the content of protein-bound [3H]25-OH-D3 in plasma that had been highly enriched with added 25-OH-D3. 30 ml of human whole serLm that had been diluted 1:1,000 (vol/vol) with PBS was added to a 40-ml tube containing 0.3 nmol of 3H-labeled 25-OH-D3 in 300 pul ethanol and incubated for 2 h at 4°C. After removal of two 1-ml portions for radioassay, 7 ml of dextran-coated charcoal was added to the remaining 28 ml to bind and remove [3H]25-OH-D3 which was not protein bound (i.e., "free"). The mixture was Vortex mixed, centrifuged for othfer vertebrate species wvas explored by double immuilllno-(lif'tlisioni in gel. Lyophilized normal sera from monkey, cow, swinie, goat, sheepl, deer, horse, cat, dog, hamister, guiinea pig, pigeon, turkey, duick, aind chiickeni were pturchased from Cappel Laboratories, Inc., Dowiningtowvn, Pa. Sera from rat and mouise were obtainied directly fromn normal animals. Tbhe presence or absenice of' immunliological cross-reactivity was assessedI (illalitatively from the immuniiiiioprecipitini lines whicl were (or were not) observed.
Otlher mrlethods atnd materials. Analytical (disc) polyacrvlamide gel electrophoresis wZas performed accordinig to two (lifferent procedtires. Procedlure 1 was identical to that employed previouisly witlh puirified DBP (1) and uised a 7% acrylamide gel (gel length 7 cm) without a concentrating gel, with a conituotis buiffer system of Tris-glycine-HCl, )H 8.1. Proceduire 2 em-iployed a 7% acrylamiiide gel of 10 cmll lenigth withouit a concenitrating gel, with a discontintuouls b)uffer systemii (Tris-glycine electrode buiffer, pH 8.3, and TrisHCl gel buffer, pH 8.9) as described by Davis (19) . Dotuble immuinodifftusion in gel xw'as carried ouit by the method of Oucilterloniy (20) uising gels prepared from 1% agarose in 0.02 M potassitumn phosphate buiffer, pH 7.2, containinig 0.15 NI NaCl and 0.01% NaN3. 20-,ul samples were uisuially applied per well. After immuinoreaction for 24-48 h, the gels were examined uinder dark-field illumination. For staining, the gels were waslhed for 3 days with PBS (+0.02% NaN3) and then with distilled water overnight before (Irying in air. Gels were stained with 0.2% (wt/vol) Coomassie Brilliant Bltue in 5% methanol-15% trichloroacetic acid (vol/vol) for 5-10 min, destainedl with 5% methanol-7.5% acetic acid for 24 
RESUL'FS
Anti-blutman DBP (alltiscrliim. 1Fhe first aintiseruimil obtained after imnmtnizatio'i f It rabbit \vith the purified DBP preparation was not monospecific, btit showed a second contaminating precipitin line on double immtunodiffusion or on immunoelectrophoresis (Fig. 1) . This indicated that although the pturified DBP preparation wvas homogeneous in the analytical tultracentrifuige and showed only a single band of protein on sodium ldodecyl stulfate-disc gel electrophoresis and on polyacrylam-ide disc gel electrophoresis by procedture 1 (1), it nonetheless contained another protein as a trace impuirity that was significantly antigenic. This contaminating protein was immutnologically identified as hlumilan a1-antitrypsin (see Methods).
A monospecific anti-huiman DBP antiseruim was suibsequiently raised in rabbits by injecting them with precipitin lines prepared by immuinoelectrophoresis, containing DBP and rabbit antibody against DBP. This antisertum gave a single precipitin line when tested against either the pturified DBP preparation or against htuman whole seruim by immuniodiffuisioni, and the lines obtained in these tests showed a reaction-of-identity with each other (Fig. 2) .
Confirmatory Radioiminrtnoassay: characteristics and restults. DBP levels were measured by radioimmiunoassay in serum samples collected from 13 Table I . Some of the same serum samples were also assayed for their concentration of 25-OH-D; the results of these assays are also summarized in Table I .
The mean (±SD) DBP level observed in 35 normal subjects was 422±27 ,ug/ml. The levels observed in men did not differ from those in women. Generally, similar values were observed in 66 hyperlipidemic men and women, although the mean value observed for the hyperlipidemic subjects (446,g/ml) was slightly (P < 0.05) higher than that of the normal subjects. No differences were observed between patients with Five patients with cirrhosis of the liver had markedly (P < 0.01) reduced serum levels of both DBP and 25-OH-D.
Two patients with vitamin D intoxication showed dramatically elevated serum levels of 25-OH-D (approximately 10 times the normal level); their DBP levels were, however, essentially normal. For (Fig. 4) .
Further evidence for the conelusion that DBP and Gc protein are the same protein was obtained by studies with DBP-depleted serum. Human whole serum was depleted of DBP by binding the DBP to anti-DBP-substituted Sepharose, as described under Methods. The DBP level of the serum before depletion was estimated as 0.45 mg/ml by RID assay. After 438 M. Imaw;ari and DeW. S. Goodman treatment with the anti-DBP-substituted Sepharose, the DBP level was found (RID assay) to be less than 0.045 mg/ml, indicating that at least 90% of the immunoreactive DBP had been removed. Untreated human whole serum and DBP-depleted serum were diluted serially with PBS and studied by immunodiffusion for immunoreactivity against commercial anti-Gc antiserum. Precipitin lines were observed (after 48 h of double diffusion) between whole serum and anti-Gc antiserum at dilutions of whole serum of up to 1:7 (vol/vol). No precipitin line was observed between undiluted (or diluted) DBP-depleted serum and anti-Gc antiserum. Thus, the DBPdepleted serum contained less than one-eighth of the level of immunoreactive Gc protein found in untreated whole serum.
Treatment of whole serum with control immunoglobulin-substituted Sepharose resulted in no decrease in the observed level of DBP (estimated by RID assay) or in the approximate level of Gc protein (estimated by immunodiffusion with serial dilutions of the treated serum).
Gc proteins have a-mobility on electrophoresis (27, 28) , whereas we have previously reported (1) that the purified DBP preparation displayed mobility similar to that of plasma albumin. To explore this potential discrepancy, polyacrylamide disc gel electrophoresis was carried out under two different sets of conditions. When electrophoresis was carried out under the previouisly used conditions (procedure 1), a single band of protein was again observed, with mobility simiiilar to that of plasma albumin. However, when procedture 2 (see Methods) was uised, the pturified DBP preparation showed a-mobility, and two very slightly separated bands of protein were observed (Fig. 5) . Thus, the electrophoretic mobility of DBP, relative to other plasma proteins, appears to be dependent upon the conditions employed. Under appropriate conditions, the purified DBP showed both the a-mobility and the microheterogeneity which have been observed by others with Ge protein (29) .
Comparative itflmunology. Serum samples from the monkey, cow, swine, goat, sheep, deer, horse, cat, and dog produced immunoprecipitin lines when tested by immutnodiffusion against the anti-htuman DBP antisertum. Seruim samples from the rat, mouse, hamster, guinea pig, pigeon, turkey, duck, and chicken did not show immunoreactivity. Monkey serum showed relatively stronger immtunoreactivity (against anti-huml-an DBP antiserum) than did the sera from the other animals tested. When sera that were immunoreactive with anti-hum1-an DBP antiserum ivere tested for immunological identity with huiman serum, they all showed patterns of partial identity. Furthermore, monkey sertum also showed patterns of partial identity with sera from the other animals.
DISCUSSION
This report describes the development of a specific radioimmunoassay and a simple and accurate radial S. p FIGURE 5 Polyacrylamide disc gel electrophoresis ofsamples of human whole serum (left) and of the purified DBP preparation (right), using Procedure 2, as described under Methods.
immunodiffusion assay for htuman DBP. The radioimmunoassay is two orders of magnitude more sensitive than the RID assay and effectively measures DBP in amounts of 1-10 ng. In contrast, the RID assay provides an effective immunoassay for DBP in amounts of 0.2-0.8 u.g. Thus, the two assays complement each other, since the RID assay is simpler to perform and more rapid, whereas the radioimmunoassay is much more sensitive and can detect much smaller quantities of DBP. The concentration of immunoreactive DBP in normal plasma is sufficiently high to permit the use of the RID assay for clinical studies involving large numbers of samples. If clinical or experimental conditions are observed, however, such that the concentration of DBP is below the range for the RID assay, the radioimmunoassay can then be employed. Moreover, the results obtained with the two immunoassays on the same samples were found to agree well with each other.
The immunoassays reported here used a monospecific antiserum against human DBP which was prepared in rabbits by injecting them with the precipitated antigen-antibody complex ( (35) . The low DBP levels fouind in these patients stuggest that DBP is also produtced in andl secreted by the liver. These observations are, moreover, consistent with evidence that has been reported previously suggesting that the liver is the principal site of Ge protein synthesis (36, 37) .
The DBP preparation used here had been isolated, as described previously (1), by an extensive se(quenice of proceduires that resulted in a final yield of only approximnately 4 mg of purified DBP from a startinig volume of 34 liters of plasma. Furthermiiore, the finial DBP preparationi appeared to have been purified approxiimatelv 13,000-fold from whole plasmia, as estimated fromi the specific radioactivity of protein-bounid [3H]25-OH-D3 (1). The question therefore arises as to how these earlier findings cani be reconciled with the results reported here of a mean normiial DBP level of 422 gtg/ml, indicating that DBP represenits more than 1/200th of the total protein in plasma.
We believe that the small yield and high degree of purification of DBP observed previously (1) resulted because of the fact that the DBP was identified (and was assayed for durinig protein fractioniation proceduires) by means of the bound tracer [3H]25-OH-D3 that had been added to plasma before fractionationi. More recent and ongoing experimiienits in our laboratory have demonstrated that some of the protein-fractionation procedures wliich were uised previously (particularly chromiiatograplhy on1 SPSephadex and Blue Sepharose 6B) separate holo-DBP (that is, DBP containing bound 25-OH-D3) from apo-DBP. Accordingly, it appears that our previous puirification sequence selectively isolated a holo-DBPenriched sample of DBP. In studies currently in progress in our laboratory, DBP-purification procedures are being monitored by immunoassay, permitting the use of a simpler and shorter purification sequence than previously employed. In addition, the possibility should be considered that plasma DBP might consist of several different subspecies of molecules which are immunologically indistinguishable, but which differ with regard to their affinity for 25-OH-D3 and (or) for other vitamin D metabolites. The known molecular heterogeneity of Ge protein (29) (i.e. of DBP) lends potential credence to this possibility. If this were the case, then our earlier purification sequence might have selectively isolated that subspecies of DBP with the highest affinity for tracer 25-OH-D3. Of interest in this regard is the fact that our extensive purification procedure (1) apparently selectively isolated the Gc 1 protein (both fast and slow bands, Fig. . polymiorphism, wvith three commoiniioi plihenotypes (Gc 1-1, Gc 2-1, anid Gc 2-2) being found in somewhat varyi ng propoitionis througlhouit the world (27, 28) . These phenotypes reflect the fact that two alleles, Gc' and GC2, are found in all humilcan popuilations. In almiiost all populationis studied, Gc' hals been fouind to be imiore commlloni thani GC2. Uncommiiiion Gc allelic variants and pheniotypes have also been observed. In a recent review (27) , it was poinlted out that publishedl data regardinig Gc phenotypes are available on mnore than 190 populations fromii all continenits comprising a total of more tlhani 75,000 individual speciimens.
The studies reportedl here confirmii and extencl the work of Daiger et al. (2) , ancd providle strong evidlence that DBP and Gc protein are indeed the same protein. On immnunodiffuision against whole serumil, the line formed with the anti-DBP antiserumii shiiowed a complete reaction-of-identitv with the line formed with commnercial antiserum against Gc protein. Furtlhermore, serum that had been depleted of DBP by treatment with anti-DBP-substituitedl Sepharose was found to be depleted also of immunoreactivity against anti-Gc protein antiserum. In addition, the properties of our ptirified DBP preparation agree closely with those previously reported for Gc protein. Thus, the amino acid composition of ptirified DBP (1) is very similar to the reported amino acid composition of Gc proteins (38, 39) . DBP was estimated to have a mol wt =52,000 (1), similar to the reported average mol wt of 50,800+2,900 for a highly purified Gc 2-2 preparation (38) . As reported here, tinder appropriate conditions, pturified DBP shows both the ai-mobility and the microheterogeneity (29) (37, 40) are also roughly similar to the DBP levels in serum reported here. All of the available evidence thus supp)orts the conclusion that DBP and Ge protein are identical. In addition, tNvo very recenit reports (published after this paper was first stubmitted for publication) have presented virtually identical findings as obserxved in our studies on the isolationi and partial characterization of the 25-OH-D-binding protein anid on its immunological identity with Ge proteini (41, 42 
